[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608354":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":33,"responsibleParty":210,"collaborators":212,"id":241,"slug":242,"hasResults":243,"nctId":244,"briefTitle":245,"officialTitle":246,"acronym":247,"eligibilityCriteria":248,"healthyVolunteers":243,"sex":249,"minAge":250,"maxAge":12,"enrollmentInfo":251,"targetDuration":12,"studyType":254,"phases":255,"briefSummary":257,"conditions":258,"keywords":260,"overallStatus":67,"whyStopped":12,"lastUpdateSubmitDate":267,"lastUpdatePostDateStruct":268,"startDateStruct":271,"completionDateStruct":273,"leadSponsor":275,"locationsCount":276},{"fullName":5,"class":6},"Radboud University Medical Center","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","NO_INTERVENTION","The control arm is a group of patients from our previous 'evaluation of care' study which underwent standard care for endometrial cancer between march of 2022 and the start of the ENDORISK-I study. This group serves as a control group for the intervention arm.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention","EXPERIMENTAL","The intervention group are patients receiving a personalized risk on lymph node metastases as predicted by the ENDORISK model, they also receive a treatment plan (hysterectomy + bilateral salpingo-oophorectomy with or without lymph node surgery) based on this personalized risk.",[18],"Diagnostic Test: ENDORISK personalized risk assesment for lymph node metastases in endometrial cancer.",[20],{"type":21,"name":22,"description":16,"armGroupLabels":23,"otherNames":12},"DIAGNOSTIC_TEST","ENDORISK personalized risk assesment for lymph node metastases in endometrial cancer.",[14],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Ruben C.G. Koek, MD \u002F Drs","CONTACT","+31631015109","ruben.koek@radboudumc.nl",{"name":31,"role":27,"phone":12,"phoneExt":12,"email":32},"Hanny M.A. Pijnenborg, MD, PhD","hanny.ma.pijnenborg@radboudumc.nl",[34,51,65,79,98,106,119,131,142,153,164,175,186,199],{"facility":35,"status":36,"city":37,"state":38,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Rijnstate","NOT_YET_RECRUITING","Arnhem","Gelderland","Netherlands","NL",{"type":42,"coordinates":43},"Point",[44,45],5.91111,51.98,{"lat":45,"lon":44},[48],{"name":49,"role":50,"phone":12,"phoneExt":12,"email":12},"Tijmen Bonestroo, MD PhD","PRINCIPAL_INVESTIGATOR",{"facility":52,"status":36,"city":53,"state":38,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Slingeland Hospital","Doetinchem",{"type":42,"coordinates":55},[56,57],6.28889,51.965,{"lat":57,"lon":56},[60,62],{"name":61,"role":50,"phone":12,"phoneExt":12,"email":12},"Kirsten Smeets, MD",{"name":63,"role":64,"phone":12,"phoneExt":12,"email":12},"Myrtille Vallen, MD PhD","SUB_INVESTIGATOR",{"facility":66,"status":67,"city":68,"state":38,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Gelderse Vallei","RECRUITING","Ede",{"type":42,"coordinates":70},[71,72],5.65833,52.03333,{"lat":72,"lon":71},[75,77],{"name":76,"role":50,"phone":12,"phoneExt":12,"email":12},"Rahul Samlal, MD",{"name":78,"role":64,"phone":12,"phoneExt":12,"email":12},"Lidewij Bartelink, MD PhD",{"facility":80,"status":67,"city":81,"state":38,"zip":82,"country":39,"countryCode":40,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Radboudumc","Nijmegen","6525GA",{"type":42,"coordinates":84},[85,86],5.85278,51.8425,{"lat":86,"lon":85},[89,92,94,96],{"name":90,"role":27,"phone":91,"phoneExt":12,"email":32},"Hanny M.A. Pijnenborg, MD PhD","+31 024 361 1111",{"name":93,"role":64,"phone":12,"phoneExt":12,"email":12},"Ruben Koek, MD",{"name":95,"role":64,"phone":12,"phoneExt":12,"email":12},"Anna Berghuis - Schoenaker, Drs",{"name":97,"role":50,"phone":12,"phoneExt":12,"email":12},"Rosella Hermens, PhD",{"facility":99,"status":36,"city":81,"state":38,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":100,"geoPoint":102,"contacts":103},"Canisius Wilhelmina Ziekenhuis (CWZ)",{"type":42,"coordinates":101},[85,86],{"lat":86,"lon":85},[104],{"name":105,"role":50,"phone":12,"phoneExt":12,"email":12},"Marc Snijders, MD PhD",{"facility":107,"status":36,"city":108,"state":38,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Streekziekenhuis Koningin Beatrix","Winterswijk",{"type":42,"coordinates":110},[111,112],6.71944,51.9725,{"lat":112,"lon":111},[115,117],{"name":116,"role":50,"phone":12,"phoneExt":12,"email":12},"Charlotte Lybol, MD PhD",{"name":118,"role":64,"phone":12,"phoneExt":12,"email":12},"Lotte van Dijk, MD",{"facility":120,"status":67,"city":121,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Jeroen Bosch Hospital","'s-Hertogenbosch","North Brabant",{"type":42,"coordinates":124},[125,126],5.30417,51.69917,{"lat":126,"lon":125},[129],{"name":130,"role":50,"phone":12,"phoneExt":12,"email":12},"Brenda Pijlman, MD",{"facility":132,"status":67,"city":133,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Amphia","Breda",{"type":42,"coordinates":135},[136,137],4.77596,51.58656,{"lat":137,"lon":136},[140],{"name":141,"role":50,"phone":12,"phoneExt":12,"email":12},"Dennis van Hamont, MD PhD",{"facility":143,"status":67,"city":144,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Catharina Hospital","Eindhoven",{"type":42,"coordinates":146},[147,148],5.47778,51.44083,{"lat":148,"lon":147},[151],{"name":152,"role":50,"phone":12,"phoneExt":12,"email":12},"Dorry Boll, MD PhD",{"facility":154,"status":67,"city":155,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"St. Anna Hospital","Geldrop",{"type":42,"coordinates":157},[158,159],5.55972,51.42167,{"lat":159,"lon":158},[162],{"name":163,"role":50,"phone":12,"phoneExt":12,"email":12},"Channa E Schmeink, MD PhD",{"facility":165,"status":67,"city":166,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"Elkerliek Hospital","Helmond",{"type":42,"coordinates":168},[169,170],5.66111,51.48167,{"lat":170,"lon":169},[173],{"name":174,"role":50,"phone":12,"phoneExt":12,"email":12},"Joris van Esch, MD",{"facility":176,"status":67,"city":177,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Elisabeth-Tweesteden Hospital","Tilburg",{"type":42,"coordinates":179},[180,181],5.0913,51.55551,{"lat":181,"lon":180},[184],{"name":185,"role":50,"phone":12,"phoneExt":12,"email":12},"Marieke Smink, MD",{"facility":187,"status":36,"city":188,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"Bernhoven Hospital","Uden",{"type":42,"coordinates":190},[191,192],5.61944,51.66083,{"lat":192,"lon":191},[195,197],{"name":196,"role":50,"phone":12,"phoneExt":12,"email":12},"Angèle Oei, MD",{"name":198,"role":64,"phone":12,"phoneExt":12,"email":12},"Jos Vollenbergh, MD",{"facility":200,"status":67,"city":201,"state":122,"zip":12,"country":39,"countryCode":40,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"Maxima Medical Center","Veldhoven",{"type":42,"coordinates":203},[204,205],5.40278,51.41833,{"lat":205,"lon":204},[208],{"name":209,"role":50,"phone":12,"phoneExt":12,"email":12},"Viola Verhoef, MD PhD",{"type":211,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[213,215,217,219,220,222,225,227,229,230,231,233,234,235,237,239],{"name":214,"class":6},"Elisabeth-TweeSteden Ziekenhuis",{"name":216,"class":6},"Amphia Hospital",{"name":218,"class":6},"Catharina Ziekenhuis Eindhoven",{"name":165,"class":6},{"name":221,"class":6},"St. Anna Ziekenhuis, Geldrop, Netherlands",{"name":223,"class":224},"Jeroen Bosch Ziekenhuis, s'-Hertogenbosch","UNKNOWN",{"name":226,"class":6},"Rijnstate Hospital",{"name":228,"class":6},"Canisius-Wilhelmina Hospital",{"name":200,"class":6},{"name":187,"class":6},{"name":232,"class":6},"Maas Hospital Pantein",{"name":52,"class":6},{"name":107,"class":224},{"name":236,"class":6},"Gelderse Vallei Hospital",{"name":238,"class":6},"Comprehensive Cancer Centre The Netherlands",{"name":240,"class":224},"Stichting PAMM","100608354","individualised-endometrial-cancer-risk-stratification-by-bayesian-prediction-model-endorisk-optimizing-clinical-implementation-100608354",false,"NCT07200466","Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation","ENDORISK Clinical Implementation Study","ENDORISK-I","Inclusion Criteria:\n\n* Diagnosed with early stage (FIGO stage I-II) endometrial carcinoma (every grade permitted)\n* Eligible for primary surgical treatment (neo-adjuvant therapy is permitted)\n\nExclusion Criteria:\n\n* Unable to give informed consent\n* No understanding of Dutch or English language\n* Rare types of endometrial cancer, such as endometrial stroma cell sarcoma","FEMALE","45 Years",{"count":252,"type":253},735,"ESTIMATED","INTERVENTIONAL",[256],"NA","Rationale: Preoperative identification of patients at risk for lymph node metastasis (LNM) is challenging in endometrial cancer (EC). Therefore, a Bayesian network model called ENDORISK was developed and validated in three external cohorts to improve preoperative risk stratification. The next step is to implement and evaluate whether use of the model improves daily clinical practice. Objective: The ENDORISK implementation (ENDORISK-I) study aims to prospectively evaluate whether implementation of ENDORISK in daily clinical practice improves preoperative risk stratification. Study design: A stepped wedge non inferiority study in which two oncology regions will consecutively start implementation of ENDORISK with one year interval. The ENDORISK model will be filled in and used in preoperative treatment counselling. Results will be compared to current standard clinical care which is prospectively evaluated in both regions since March 2022 in the 'evaluation of care in endometrial cancer' study (2021-7400). Study population: all consecutive patients recently diagnosed with early stage EC who are eligible for surgical treatment, who understand Dutch and are able to fill in a digital or paper questionnaire can be included. Main study parameters\u002Fendpoints: The ENDORISK implementation (ENDORISK-I) study aims to prospectively evaluate implementation of ENDORISK in daily clinical practice by investigating:\n\n* The proportion of identified LNM in patients with lymph node staging (positive predictive value (PPV)) compared to standard care\n* Proportion of patients who decide to have lymph node status assessed in ENDORISK care compared to standard care\n* Preoperative information provision for patients and shared-decision making with the use of ENDORISK compared to standard care\n* Patients' disease- specific-, overall survival, and health-related quality of life compared to standard care\n* Patients' and doctors' use of and experiences with the ENDORISK-model\n* Impact of ENDORISK on regional care costs",[259],"Endometrial Cancer",[261,259,262,263,264,265,266],"ENDORISK","surgical staging","risk stratification","lymph node metastases","lymphadenectomy","sentinel node","2026-06-17",{"date":269,"type":270},"2026-06-22","ACTUAL",{"date":272,"type":270},"2025-10-23",{"date":274,"type":253},"2032-10-16",{"name":5,"class":6},14]